オハイオにおける急性腎障害の臨床試験
オハイオ内の拠点で、急性腎障害に関する11件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- MetroHealth, Cleveland
- Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/09/25更新 · NCT05805709Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- University of Cincinnati, Cincinnati
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
被験者募集中
18歳以上 · 全性別 · 2026/09/10更新 · NCT05758077Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Cincinnati, Cincinnati
- The Ohio State University, Columbus
被験者募集中第2相
12歳以上 · 全性別 · 2026/08/14更新 · NCT06699849Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中第2相
18歳以下 · 全性別 · 2026/07/24更新 · NCT07212595FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/22更新 · NCT07718464Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- Children's Hospital Medical Center, Cincinnati
- University Hospitals Rainbow Babies & Children's Hospital, Cleveland
- Nationwide Children's Hospital, Columbus
被験者募集中
9 Months – 21 Years · 全性別 · 2026/05/18更新 · NCT05219110QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Cincinnati Children's Hospital, Cincinnati
- Cleveland Clinic Children's Hospital, Cleveland
被験者募集中観察研究
22歳以下 · 全性別 · 2026/05/14更新 · NCT06517810Kidney Precision Medicine Project
- Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/14更新 · NCT04334707Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- University of Cincinnati, Cincinnati
被験者募集中
22歳〜85歳 · 全性別 · 2026/03/19更新 · NCT07017933Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- Cincinnati Children's Hospital Medical Center, Cincinnati
被験者募集中
18歳〜80歳 · 全性別 · 2025/10/15更新 · NCT06150742Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
- Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2022/09/28更新 · NCT04669548ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。